Research Topics
| P BraitsteinSummaryAffiliation: University of Bern Country: Switzerland Publications
| Collaborators
|
Detail Information
Publications
Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment programPaula Braitstein
British Columbia Centre for Excellence in HIV AIDS, University of British Columbia, Vancouver, Canada
J Infect Dis 193:259-68. 2006..We sought to characterize the impact that hepatitis C virus (HCV) infection has on CD4 cells during the first 48 weeks of antiretroviral therapy (ART) in previously ART-naive human immunodeficiency virus (HIV)-infected patients...- Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohortPaula Braitstein
British Columbia Center for Excellence in HIV AIDS, University of British Columbia, Vancouver, Canada
AIDS 20:323-31. 2006..To characterize the impact of hepatitis C (HCV) serostatus on adherence to antiretroviral treatment (ART) among HIV-infected adults initiating ART... 
Effect of serostatus for hepatitis C virus on mortality among antiretrovirally naive HIV-positive patientsPaula Braitstein
Institute for Social and Preventive Medicine, University of Berne, Berne, Switzerland
CMAJ 173:160-4. 2005..We examined the effect of hepatitis C virus (HCV) seropositivity on risk of death among people receiving their first antiretroviral treatment (ART) for HIV infection...- Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C aloneP Braitstein
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
AIDS Care 18:690-3. 2006..54; 95% CI: 0.36-0.82) and believing that hepatitis C was affecting one's health (AOR 1.4; 95% CI: 1.0-2.1). In conclusion, our data indicate more HCV healthcare utilization among those HIV/HCV-co-infected... - Sexual violence among two populations of men at high risk of HIV infectionPaula Braitstein
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
AIDS Care 18:681-9. 2006..Sexual violence is differentially associated with different health risk behaviors, depending on the age at first occurrence and the primary HIV risk factor (i.e. MSM vs. IDU)... - Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohortP Braitstein
Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
AIDS Care 17:505-15. 2005..Although these patients experience poorer quality of life, increased depression and fatigue, this experience appears to be primarily related to socio-economic issues rather than HCV infection... - Use of antiretroviral therapy among HIV positive individuals living in British ColumbiaM Rusch
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, University of British Columbia, Vancouver, Canada
AIDS Care 16:914-22. 2004..The differences in current antiretroviral use by sociodemographic characteristics such as IDU suggest that the need remains to target marginalized populations in order to maximize the health benefits from antiretroviral therapy... - Tuberculosis in HIV programmes in lower-income countries: practices and risk factorsL Fenner
Institute of Social and Preventive Medicine, Berne, Switzerland
Int J Tuberc Lung Dis 15:620-7. 2011..Tuberculosis (TB) is a common diagnosis in human immunodeficiency virus (HIV) infected patients on antiretroviral treatment (ART)... - Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaborationSuely H Tuboi
Infectious Diseases Epidemiology Research Unit, Graduate School of Public Health and School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
J Acquir Immune Defic Syndr 45:52-9. 2007..To assess the frequency of and risk factors for discordant responses at 6 months on highly active antiretroviral therapy (HAART) in previously treatment-naive HIV patients from resource-limited countries... - Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesPaula Braitstein
Lancet 367:817-24. 2006..Timely diagnosis and assessment of treatment eligibility, coupled with free provision of HAART, might reduce this excess mortality... - Risks of non-accidental mortality by baseline CD4+ T-cell strata in hepatitis-C-positive and -negative individuals initiating highly active antiretroviral therapyDavid M Moore
BC Centre for Excellence in HIV AIDS, Vancouver, British Columbia, Canada
Antivir Ther 11:125-9. 2006..We designed a study to determine whether risks for later mortality are similar for HCV-positive and HCV-negative individuals when subjects are stratified on the basis of baseline CD4+ T-cell counts... - Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countriesMartin W G Brinkhof
Institute of Social and Preventive Medicine ISPM, University of Berne, Finkenhubelweg 11, CH 3012 Bern, Switzerland
Clin Infect Dis 45:1518-21. 2007..48 (95% confidence interval, 0.36-0.64) in low-income countries and 0.36 (95% confidence interval, 0.26-0.50) in high-income countries. A low CD4 cell count at the start of therapy was the most important risk factor in both settings... 
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaborationPaula Braitstein
Department of Medicine, Indiana University, Indianapolis, Indiana, USA
J Womens Health (Larchmt) 17:47-55. 2008....- Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin AmericaOlivia Keiser
Institute of Social and Preventive Medicine ISPM, University of Bern, Finkenhubelweg 11, 3012 Bern, Switzerland
Trop Med Int Health 13:870-9. 2008..To describe temporal trends in baseline clinical characteristics, initial treatment regimens and monitoring of patients starting antiretroviral therapy (ART) in resource-limited settings... - Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapyDavid M Moore
British Columbia Centre for Excellence in HIV AIDS, 608 1081 Burrard Street, Vancouver, British Columbia, Canada V6Z 1Y6
J Acquir Immune Defic Syndr 40:288-93. 2005..To examine the independent association of discordant virologic and immunologic responses to highly active antiretroviral therapy (HAART) with mortality... - Safety and tolerability of combination antiretroviral post-exposure prophylaxis in a population-based settingPaula Braitstein
J Acquir Immune Defic Syndr 29:547-8. 2002 - Sexual violence among a cohort of injection drug usersPaula Braitstein
British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC, Canada
Soc Sci Med 57:561-9. 2003..Nevertheless, women and men are affected differently by sexual violence at different ages, and this has significant implications for health promotion programs, and specifically HIV prevention... - Interventional cardiovascular procedures among HIV-infected individuals on antiretroviral therapy 1995-2000Paula Braitstein
British Columbia Centre for Excellence in HIV/AIDS, University of British Columbia, Vancouver, British Columbia, Canada
AIDS 17:2071-5. 2003..CONCLUSIONS: The rate of ICP among HIV-positive individuals on ART appears to be increasing; in addition, the duration of time on ART is independently associated with ICP after adjustment for patient demographic characteristics... - Age, adherence and injection drug use predict virological suppression among men and women enrolled in a population-based antiretroviral drug treatment programmePaula Braitstein
BC Centre for Excellence in HIV/AIDS, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
Antivir Ther 8:569-76. 2003..CONCLUSION: Our data indicate that in this population-based setting, sex differences in 1-year virological response to antiretroviral therapy are explained by age, adherence and injection drug use... - The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug usersCari L Miller
British Columbia Centre for Excellence in HIV AIDS, Vancouver, and Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada
J Acquir Immune Defic Syndr 36:743-9. 2004..The median number of years injecting for youth seroconverting to a secondary infection was 3 years, suggesting that appropriate public health interventions should be implemented immediately... - Impairments, activity limitations and participation restrictions: prevalence and associations among persons living with HIV/AIDS in British ColumbiaMelanie Rusch
Department of Population Health, British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, Vancouver, Canada
Health Qual Life Outcomes 2:46. 2004..To measure the prevalence of and associations among impairments, activity limitations and participation restrictions in persons living with HIV in British Columbia to inform support and care programs, policy and research... - Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis CPaula Braitstein
British Columbia Center for Excellence in HIV AIDS, University of British Columbia, Vancouver, Canada
AIDS 18:2221-34. 2004..Evidence is accumulating regarding the impact of HIV/HCV coinfection on the response to, and safety and tolerability of, antiretroviral therapy (ART) in this population... - Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohortsFrancois Dabis
INSERM U 593, ISPED, Universite Victor Segalen, Bordeaux Cedex, France
Int J Epidemiol 34:979-86. 2005 - Prescribing practices in a population-based HIV postexposure prophylaxis programPaula Braitstein
Division of Epidemiology and Population Health, BC Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada
AIDS 16:1067-70. 2002..Receiving the remaining 23 days PEP was associated with being male, experiencing a community mucocutaneous or needlestick injury, and triple therapy as the initial 5 day starter PEP... - Prevalence of activity limitation among persons living with HIV/AIDS in British ColumbiaMelanie Rusch
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, and University of British Columbia, Vancouver, BC
Can J Public Health 95:437-40. 2004..Little research has examined the types and levels of activity limitations among HIV-positive populations. The objective of this report is to compare the levels of limitations among HIV-positive persons to the general population... - Influence of human papillomavirus type 16 (HPV-16) E2 polymorphism on quantification of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasiaNaoufel Azizi
Laboratoire de Virologie Moleculaire, Centre de recherche du Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
J Gen Virol 89:1716-28. 2008..24) or CIN-1 (5 of 14, P=0.50). HPV-16 E2 polymorphism was a significant factor that influenced measures of HPV-16 integrated viral load...